Tuesday, November 27, 2012

Nardox - Natural Sleep Medication (Monograph)

Nardox - Sleep Aid Capsules


Nardox helps in inducing natural sleep and restores mental peace. It reduces anxiety, restlessness and aggressiveness. And the best part is, it has no side effects, hangover or sedation. It is safe and non habit forming.

Following herbs are used in ful in inducing natural sleep:

Nardostachys jatamansi
Valeriana wallichii
Acorus calamus
Tinospora cordifolia

Nardostachys jatamansi

It is reported to have tranquilizing properties as per Ayurveda. It has been used alone or in the combination with TAGAR (Valerian wallchii) to relieve the anxiety symptoms. The infusion of root is administered in hysteria, palpitation of heart & other nervous diseases like convulsion & epilepsy.

Valeriana wallichii

Roots & rhizomes of Valeriana wallichii are used as sedatives & tranquilizer for the treatment of nervousness & hysteria. Valepotriate the active constituents possess definite sedative & tranquilizing activity in mice, cat & human. The root extract can be used as a day time sedative. A study conducted in 30 patients with anxiety disorder. Valeriana wallichii in combination with other was found to be useful in relieving anxiety symptoms.

Acorus calamus

Acorus calamus contains an essential oil having tranquilizing & sedative properties. In ayurveda it is used as anti- epileptic, psychoactive drug & has been reported to cure insanity & possess depressant action.

Tinospora cordifolia

Tinospora cordifolia is used as a general tonic & as a adaptogenic.The root possesses anti stress properties. When clinically evaluated for the anti stress & general health tonic properties, moderate degree of behavioral disorders, anxiety, restlessness & mental disorder were significantly improved by Tinospora cordifolia.

Indication & uses:

* Sleep disturbance, Insomnia

* Emotional stress, Irritability

* Anxiety, Tension

* Nervousness, Palpitation

* Natural sleep aid

Monograph:



Ever since the philosopher Descartes has separated the transcendent mind from the mechanical operations of the body, science has been even more concerned with accurately resolving the body into its component parts. People have come to view all illness as primarily a malfunction of the mechanical parts
 
(i. e. body) and have lost sight of the importance of the psychological, social and environmental influences on health & illness, and of the extraordinary power of the mind to effect the body. Mood, attitude and belief can affect virtually every chronic illness.

Apparently disorders of (diseases affecting) mood, emotion and attitude i.e. neuropsychological disorders has implication on the entire human system.

ANXIETY
               
Anxiety, characterized by abnormal nervous tension and distortion of thinking, is not cardinal symptom of many psychiatric disorders, but also an almost inevitable component of many medical and surgical conditions. It is a universal human emotion, closely allied with appropriate fear and often serving psychologically adaptive purposes. An important clinical generalization is that anxiety is rather infrequently a “disease” in itself, although in truth the anxiety associated with many of the psycho-neurotic disorders, often seems to have an incomprehensible life of its own. Thereby emphasizing the necessity for anti-anxiety medications which can be frequently, appropriately and safely used for treating primary and secondary anxiety.

CURRENT ANTIANXIETY THERAPY:

The primary characteristics of anti-anxiety drugs in contrast to many other drugs that act on central nervous system, is that they alter the mental state and behavior in a predictable way.

While pharmacotherapy with anti-anxiety drugs does not cure mental disorders in the same sense that antibiotic cure infectious diseases, the available drugs do control most symptomatic manifestations, behavioral deviance and facilitate the patient’s tendency towards remission. Hence improves his/ her capacity for social, occupational and familial adjustment.

Anti-anxiety drugs, like other drugs used in psychiatry, can cause a wide range of adverse effects. Many physiological systems may be affected, but central nervous system (especially the higher cerebral functions) is particularly vulnerable. The most common of all adverse effects is over sedation and hangover. This is a serious problem while driving and while working in dangerous situations. Other major side effects are impairment of intellectual functions, behavioral and performance discrepancy, drowsiness and general apathy. Another major disadvantage of currently prescribed anti-anxiety drugs is development of drug tolerance, dependence and withdrawal symptoms like reflux anxiety, restlessness, agitation, insomnia, delirium, convulsions and hypertension.

The aforementioned disadvantages of currently prescribed anti- anxiety drugs necessitate the need to develop new and safer anti-anxiety drugs. In compliance with the same quest, Nirvana Wellness has formulated a new herbal product, NARDOX, as an effective Sleep-Aid.



NARDOX: AN IDEAL TRANQUILIZER.

NARDOX a herbal tranquilizer, is based on a balanced formula derived from Medhya Rasayana drugs of ancient Indian form of medicine- AYURVEDA. Each herb included herein has been reported to counteract the Anxiety State by tranquilizing the patient. They also improve the memory span and intelligence.

NARDOX, is an Herbal Sleep – Aid, has an edge over conventional antianxiety drugs, because:

Being a herbal preparation, it is safe and does not affect higher function.
It is devoid of any side effect like over sedation, hangover etc.
It does not produce drug tolerance, dependence and drug withdrawal symptoms.

Hence NARDOX can be very safely used to reduce anxiety, tension, irritability, palpitation and also to improve memory, thereby justifying the use of NARDOX as a “nervine tonic”. The various medicinal herbs included in the formulation, along with their common names are Nardostachys jatamansi (Jatamansi), Tinispora cordifolia (Gudduchi), Valeriana wallichii (Tagar) and Acorus calamus (Vacha).

The subsequent discussions provide a rationale for inclusion of each of the aforementioned herbs in the currently introduced formulation: -


NARDOSTACHYS JATAMANSI:

N. jatamansi (Fam: valerianacae), commonly known as Jatamansi. Charaka , Sushruta and Vagbhatta, the three ancient manuscripts of Ayurveda, has recommended Jatamansi most frequently in treatment of mental disorders as a sedative and tranquilizer. N. jatamansi contains essential oil – Jatamansone, a ketonic sesquiterpene as its major biologically active constituent. It also contains Jatamansic acid as one of its constituents.

PHARMACOLOGY AND CLINICAL TRIALS :

N. jatamansi has been universally known for its tranquilizing properties in the Indian system of medicine – Ayurveda. It has been used in Ayurveda, either alone or in combination with Valeriana jatamansi for treating various anxiety disorders. The infusion of roots is administered in hysteria, palpitation of heart and in various other nervous diseases like epilepsy and convulsions (Arora, 1965).

Jatamansone also exerted tranquilizing action in mice and monkey (Arora et al., 1962). The oil , also potentiated phenobarbital –induced narcosis in rats, reduced the conditional avoidance response in cats and reduced the rat brain serotonin content (Hamied et al ., 1962). The mode of action of Jatamansone is to reduce the brain levels of 5 hydroxytryptamine by impairing the biosynthesis of serotonin in the brain tissue (Arora et al .,1962).

In an open trial of 4 weeks in 25 patients with anxiety disorders, N. Jatamansi in combination with other herbal drugs was found to be useful in relieving the anxiety symptoms, wherein the onset of action was observed by the end of 2nd week and the maximum response by the end of the 4th week (Shah, et al., 1994). A double blind clinical trial conducted in 28 hyperkinetic children below 14 years of age for 11 months showed that jatamansone improved the behaviour significantly (Gupta et al., 1968). Jatamansone was also found to reduce the mental symptoms in the schizophrenic patients (Mahal et al., 1976).

            In Ayurveda, Jatamansi has been reported to improve intellect and memory. The root infusion can be used in treatment of menopausal symptoms and indigestion (Thakur et al ., 1989). Jatamansone also exhibited anti- emetic properties in dogs and reduced aggressiveness in monkeys (Rastogi et al., 1990).



TINOSPORA CORDIFOLIA:

T. cordifolia (Fam : Menispermaceae) commonly known as Guduchi. It has been reported to possess a wide range of therapeutic activity. It has been used in the traditional system of medicine as an Indian bitter. In Ayurveda, the drug is administered along with piper longum root , to prevent gastric degradation of food materials and to improve the digestion. It contains Tinosporin, Tinosporon, Cordifolide, Tinosporon and Tinosporine as its major biologically active
constituents. The leaves also contain octasanol and beta – sitosterol (Dixit et al., 1971; Kudrat – I –Khuda, 1964).

PHARMOCOLOGY AND CLINICAL TRIALS:

In Ayurveda, T. cordifolia categorised as “Rasayana” is used as a general tonic and as an adaptogenic. The root possesses anti stress properties (WOI, 1976; Thatte and Dahanukar, 1989). Mortality rate in E. coli induced peritonitis was significantly reduced with T. cordifolia treatment (Dahanukar et al., 1988 ; Rage et al., 1989).
Sheth et al., (1991) and Sharan et al., (1991) have clinically evaluated the antistress and general health tonic properties of T. cordifolia wherein moderate degree of behavioral disorders and mental disorders were significantly improved. Increase in IQ levels was also significant. T. cordifolia also protected cholestatic patients against E. coli infection (Thatte et al., 1989).

The root possess antileprotic and anti- malarial activity (WOI,1976). The extracts of T. cordifolia showed hepatoprotective effect against carbon tetrachloride induced hepatotoxicity (peer et al., 1989).

3). VALERIANA WALLICHII:

                V. wallichii (Fam: Valerianaceae) commonly known as Tagar. In Ayurveda, the extracts of V. wallichii have been cited for its neuroleptic and sedative properties. V. wallichii contains valepotriates (triesters of polyhydroxy alcohol with valeric, isovaleric and isocaproic acid) as its active constituents. The other constituents identified are archidic acid, haspertonic acid and caproic acid.

PHARMACOLOGY AND CLINICAL TRIALS:
               
Roots and rhizomes of V. wallichii are used as sedative and tranquilizer for the treatment of hysteria, nervous unrest, hypochondriasis and similar emotional states. Valepotriates were found to possess definite sedative and tranquilizing activity in mice, cats and humans. Valepotriates has also been reported to improve coordination and diminish restlessness, anxiety and aggressiveness in animals without adverse effect on reactivity (Klaus et al., 1969). The hypnotic effect in mice was antagonized by a mixture of Valepotriates (100 mg/ kg orally) (Klaus et al., 1969). It also exerted sedative, spasmolytic, CNS depressant and antitumour effect (Sharma et al., 1989). The root extract can be used as day- time sedative since it does not have synergy with alcohol and doesn’t slow down the reflexive response (Hobbs, 1990; Monograph, German Min. Health, 1989).
           
Twenty epileptic patients were tested for cognitive functions following sodium valproiate monotherapy. Progressive improvement in attention, intelligence, immediate recall and visuospatial functions, with no charge in orientation and recent and remote memory was observed (Jha et al., 1992). In another open trial of 4 weeks conducted in 30 patients with anxiety disorders, V. wallichii in combination with other herbal drugs was found to be useful in relieving anxiety symptoms , wherein onset of effect and maximal effect was observed by the end of 2nd  and 4th week respectively. Long term treatment upto 12 weeks improved the efficacy of the drug quantitatively, but was found to be devoid of any side effects (Shah et al ., 1994).

4). ACORUS CALAMUS:

A.calamus (Fam: Araceae) commonly known as Vacha. The plant extracts have been extensively used in the traditional Indian system of medicine as a sedative, in the treatment of epilepsy, insanity, and as a tranquilizer. It contain the two isomeric substances, Asarone and B- Asarone as its major, biologically active chemical constituent.

PHARMACOLOGY AND CLINICAL TRIALS:

A.calamus essential oil was found to possess tranquilizing and sedative properties comparable to that of chlorpromazine and reserpine (Handa, 1994). In Ayurveda, A. ocalamus is used as antiepileptic , psychoactive drug and has been reported to cure insanity, promote intellect and intelligence. The aqueous and alcoholic root extracts exhibits depressant action (Bose et al., 1960). The extracts are also used in treatment of petitmal epilepsy (Martis et al., 1991). Essential oils of A. calamus also showed sedative and tranquilizing action in rats, cats and dogs (Rastogi et al., 1965; Sharma et al., 1961).

Asarone and B- Asarone has been reported to potentiate the hypnotic activity of anaesthetic agents, produce significant reduction in rectal temperatures in mice and shows anti- cholinergic action in mice (Sharma et al., 1961; Rastogi et al., 1962).
           
In an open trial of 4 weeks A. calamus in a composite formulation was reported to be useful in relieving anxiety symptoms in 30 patients with anxiety disorders. In long term A. calamus (for 12 weeks) showed quantitative improvement in alleviating anxiety disorders without producing any side effects (Shah et al., 1994).
           
The essential oils also showed smooth muscle relaxant properties as well as antispasmodic action against various spasmogens (Dhalla et al., 1962). It is also useful in preventing electrically induced convulsions in hind limbs of the rats (Madan et al., 1960). It blocks the neuromuscular junctions, both pre and post synoptically by interfering with the calcium and magnesium ion effects respectively (Panchal et al., 1989). Both asarone and B- asarone showed cardiac depressant activity, along with stoppage of frog heart in diastole and moderate hypotensive action in anaesthesised dogs. (Rastogi et al., 1990).





REFERENCES:

Arora R. B., (1965).ICMR New Delhi.

Arora R. B,.Singh M. and Chandra K., (1962). Life Sci, 6: 225.

Bose B. S., Vijayavargiya R.,Saiji A. Q. and Sharma S. K.  (1960). J. Amer. Pharm. Ass., 49 :32.

Dahanukar S. A., Pai P. M., Thatte U. M., Dube B. L. and Dasi R. G., (1989). Indian J. Gastroenterol ., 7 (1) : 21.

Dhalla N. S. and Bhattacharya I. S.,(1968). Arch. Int, Pharmacodyn. 172 : 356.

Dixit S. N. and Khosa R. L.,(1971). Indian J. Appl. Chem., 34 : 46.

Gupta B. D. and Virmani V.,(1968). Neurology (India), 16 : 168.

Hamied K. A., Bakshi V. M. and Aghara L. M.,(1962). J. Sci. Ind. Res., 21c : 100.

Handa S. S., (1994). Pharma Times, 3 : 17- 25.

Hobbs C.,(1989). Herbalgram, 21 : 19-34.

Jha S., Nag D., Shukla R., Saxena R. C. Trivedi J. K. and Kar A. M., (1992). Indian J. Pharmacol., 24 : 219-222.

Klaus  W., Von Eicckstedt. and Rahman S., (1969). Arzneim. Forsch, 19 : 316.

Madan  B. R., Arora R. B. and Kapila K., (1960). Arch. Int. Pharmacodyn., 1224 : 201.

Mahal R. S., Chaturvedi D.D., Thomas K. M., Senapati H. M., Rama M. G. and Murthy, N. N., (1976). Indian J. Psyc., 18 : 283.

Martis G., Rao A. and Karanth K, S.,(1991). ,itoterapia, 62 : 331- 337.

Panchal G. M., Venkatakrishna R., Bhatt K.,Vajpayee S. and Doctor R. B., (1989). Indian J. Exp. Biol., 27(6) : 561 – 567.

Peer F. and Sharma M. C., (1989). Indian J. Vet. Med., 9(2) : 15.

Qudrat –I-khuda M., Khaleque A. and Roy N.,(1964). Chem. Abstr., 61 : 12331.

Rastogi R. P. and Mehrotra B. N., (1969). In : Compendium of Indian Medicinal Plants, Vol. 1. (1960 – 1969). CSIR and PID, New Delhi (India) pp 8 –9, 286

Rege N. N., Nazareth H. M., Bapat R. D. and Dahanukar S. A., Indian J. Med. Res., 90 : 478.

Shah L. P., Hanumantha K. and Seena B.,(1994). Update Ayurveda, Pub. Ayurveda Research Centre, KEM Hospital, Mumbai, India. pp 55.

Sharan R. and Khare R.,1991). Probe, 31(1) : 12.

Sharma J. D., Dandiya P. C., Baxter R. M., and Kandel S. I., (1961). Nature, 192 : 1299.

Sheth S. C., Tibrewala N. S., Pai P. M., Dube B. L. and Dasi R. G., (1991). Probe, 30 (3) : 222.

Thakur R. S., Puri H. S. and Hussian A., (1989). Major Medicinal Plants of India. Pub. CIMAP. India. pp 361.

Thatte U. M. and Dahanukar S. A., (1989). Phytother. Res., 3 (2) : 43.

Anon. (1976). Wealth of India (Raw Materials), Vol. X. CSIR, New Delhi, India. pp 251.

Anon.(1985) Monographs for Phytomedicines., Valerian Commission E. German Ministry of Health. Bonn. Germany



 

No comments:

Post a Comment